Patient-Specific Glandular Dose Estimation in Mammography Using Tissue Distribution Models
Researchers have developed a framework to estimate patient-specific bounds on normalized glandular dose (DgN) in mammography using projection-derived glandular fraction maps. Current dosimetry models rely on population-based tissue distributions, but glandular tissue depth—which significantly affects dose—cannot be determined from a single mammographic image. The work matters because DgN can vary by up to a factor of three depending on glandular tissue depth alone, meaning existing estimates may meaningfully over- or underestimate radiation risk for individual patients.
A new preprint posted to arXiv proposes a computational framework for bounding the normalized glandular dose (DgN) a patient receives during mammography, using glandular fraction (GF) maps estimated from a single mammographic projection. Because mammography employs ionizing radiation, accurate dose estimation is important for cancer risk assessment, yet conventional projections cannot reveal where glandular tissue sits within the breast's depth. The researchers used Siddon ray-tracing to simulate three glandular tissue configurations—top, center, and bottom placement—that all produce identical GF maps and visually indistinguishable images, then ran Monte Carlo simulations to calculate DgN for each. Results showed DgN varied by up to a factor of three across configurations solely due to depth differences. Compared to a central placement reference, central placement overestimated dose by less than 5% (MLO view) and 15% (CC view) on average, while centroid-based placement underestimated dose by up to 25%. The authors conclude that central glandular placement serves as a conservative upper-bound estimate and that patient-specific DgN ranges can be derived from limited mammographic data, potentially improving on the population-based approach used in current standards such as TG-282.
What's missing
The study relies entirely on simulated data; validation against physical breast phantoms or clinical patient data has not yet been performed. It is also unclear how the framework would perform for breasts with highly heterogeneous or unusual glandular distributions not well represented by the TG-282 population model. The clinical pathway for integrating patient-specific DgN bounds into routine mammography practice is not addressed.
What different sources said
- arXiv physicsCenter
Range of Normalized Glandular Dose for Mammography Using Patient-Specific Glandular Fractions
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.